Imunon, Inc. Form 8-K Summary
Business Context and Reporting Period
This Form 8-K was filed by Imunon, Inc. (IMNN) on August 28, 2025, reporting an event that occurred on August 27, 2025. The Company is incorporated in Delaware and its common stock trades on the Nasdaq Capital Market.
Key Financial Metrics
This filing does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The document is a current report regarding listing status only.
Material Changes
The primary material event reported is the Company's regained compliance with the Nasdaq Listing Rule 5550(a)(2) Minimum Bid Price Requirement. On August 27, 2025, the Nasdaq Hearings Panel notified Imunon, Inc. that it has satisfied the $1.00 minimum closing bid price requirement for continued listing on the Nasdaq Capital Market.
Guidance, Outlook, and Risks
The filing contains no management guidance, forward-looking outlook, or discussion of risks and contingencies beyond the resolution of the specific listing deficiency. No unusual items were reported.
Investor Verification Checklist
- Verify the current trading price of IMNN to confirm sustained compliance with the $1.00 minimum bid price.
- Review the attached Press Release (Exhibit 99.1) for any additional context regarding the Company's capitalization or market conditions.
- Check subsequent filings for any new delisting notices or compliance issues.